Columns
Owners or licensees of Australianpatents can be more bullish aboutasserting them as they now haveless concerns over invalidation thanthey would in many other countries
The failures of the US healthcaremarket are exacerbated by a lack ofproper scrutiny of how VCs and otherinvestors in the sector evaluate IP
Those who are happy to continueinfringing IP rights once theinfringement becomes clear shouldspend some time in jail. That wouldconcentrate minds a lot quicker thanmechanisms such as treble damages
In the developing knowledgeeconomy, the traditional divides thatseparate universities from industryare not sustainable
When it comes to understandingwhat innovation rights such aspatents mean to public companyperformance, CEOs are hiding inplain sight
Features
Indices based around rating the performance of quoted companies’IP management and performance have been with us for a few years now.Recent research shows the returns investors in one would have enjoyedover a six month and one year period
It may not be worth putting intangibles on a balance sheet, but includingthem in management commentaries is a completely different matter
Over the last few years, IBM has been a pivotal player in the developmentof the patent system and in exploring the financial possibilities it offers.Now Big Blue’s top IP lawyer is at it again
While many may see KSRas helpful to patent infringers, a close readingof the decision reveals that the opposite may, in fact, be the case
The European Patent Conference was launched by the FFII, a group bestknown for taking a hard line against software patents. By bringing differentstakeholders together, the hope is that dialogue will replace confrontationas a way to build an effective European patent system
Although there was something for everyone in the KSRdecision, the realwinners will ultimately turn out to be members of the patent bar
When the CEO of Procter & Gamble decided that 50% of the company’sproducts should be developed collaboratively, a new internal businessgroup was born. Seven years on, it is ensuring the boss is getting exactlywhat he wants
Since first quarter 2006, mostpharma companies have increasedtheir patent portfolios. Therealignment is most closely tied todifferences in research intensity.
Insights
The new president of theEuropean Patent Officewill have her work cut outas she tackles a numberof high-profile issues.If Alison Brimelow playsher cards right, however,she could find allies atthe very top of Europe’spolitical ladder
Industry insight
As companies strive for newsources of value creation, with manyturning to their patent portfolios asan asset base for exploitation,CPA’s John Pryor looks at ways tostay ahead of the competition
Management report
There is no doubting that these daysoutsourcing is a multi-billion dollarbusiness. And it is not hard to see why,as companies are in a position to savesubstantial amounts of money when theysend out work to be done by third partiesat a fraction of the amount it would cost forthe same to be done in-house
Roundtable
Four experts from some of the leading firms in Asia and the Pacific Rimdiscuss key IP issues facing their jurisdictions
